|
- Optilume® for Urethral Stricture | Urethral Drug Coated Balloon
For patients who have failed prior endoscopic treatment, today there is Optilume® — a breakthrough urethral drug-coated balloon treatment that dilates the urethral lumen and delivers paclitaxel directly to the stricture, significantly reducing the incidence of stricture recurrence 1,2
- Optilume, a minimally invasive solution for BPH and urethral stricture . . .
Optilume is an innovative, minimally invasive treatment that utilizes a drug-coated balloon (DCB) technology to address two common urological conditions: Benign prostatic hyperplasia (BPH) and urethral strictures
- Optilume Procedure for Urethral Stricture - Austin Urology Institute
The Optilume Drug-Coated Balloon is an exciting new development in the world of urology Its ability to treat strictures in a minimally invasive way while reducing the risk of recurrence makes it a promising option for many patients
- Urotronic - Optilume
The Optilume drug-coated balloon is an exciting innovation in urethral stricture treatment—giving patients and physicians an effective solution that can deliver sustained patency and long-term relief
- Optilume BPH Catheter System – P220029 | FDA
The Optilume BPH Catheter System is used to treat benign prostatic hyperplasia (BPH) in men age 50 and older
- Optilume® Treatment | Steinberg Urology
Optilume® is a medication-coated balloon that integrates specialized drug delivery technology and balloon dilation techniques The treatment opens the urethra to slow or stop the regrowth of strictures and helps reduce Benign Prostate Hyperplasia (BPH) symptoms
- Optilume® BPH Catheter System for the treatment of BPH - Laborie
Introducing the next-generation of minimally invasive BPH treatment The Optilume® BPH Catheter System revolutionizes the treatment paradigm by providing immediate and durable symptom relief for men experiencing BPH induced lower urinary tract symptoms
- Single-center prospective experience with Optilume - Springer
Background Urethral stricture disease remains a challenging condition in urology, particularly in cases with recurrent anterior urethral narrowing following prior endoscopic treatments Traditional options such as dilation and direct vision internal urethrotomy (DVIU) are limited by high failure rates The Optilume® drug-coated balloon (DCB) delivers mechanical dilation combined with
|
|
|